Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.

Literature DB >> 18024862

Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.

Mark A Socinski, Thomas E Stinchcombe.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 18024862 DOI： 10.1200/JCO.2007.13.4015

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Recent development on statistical methods for personalized medicine discovery.

Authors: Yingqi Zhao; Donglin Zeng
Journal: Front Med Date: 2013-02-02 Impact factor: 4.592

2. Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.

Authors: Yufan Zhao; Donglin Zeng; Mark A Socinski; Michael R Kosorok
Journal: Biometrics Date: 2011-03-08 Impact factor: 2.571

3. Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

Authors: Charu Aggarwal; Hossein Borghaei
Journal: Onco Targets Ther Date: 2009-02-18 Impact factor: 4.147

4. Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.

Authors: Luis G Paz-Ares; Sedat Altug; Alexandra Thareau Vaury; Jesús Corral Jaime; Francesca Russo; Carla Visseren-Grul
Journal: BMC Cancer Date: 2010-03-08 Impact factor: 4.430

Review 5. Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.

Authors: Hamid R Mirshahidi; Chung T Hsueh
Journal: J Hematol Oncol Date: 2010-05-02 Impact factor: 17.388

Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.

Review 1. Recent development on statistical methods for personalized medicine discovery.

2. Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.

3. Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

Review 5. Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.

6. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.

7. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

8. Constructing dynamic treatment regimes with shared parameters for censored data.

9. Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.

Review 10. Treatment options for small cell lung cancer - do we have more choice?